ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.

NVTA Invitae Corporation

0.0891
0.00 (0.00%)
30 4월(4) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Invitae Corporation NVTA NYSE 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.00 0.00% 0.0891 09:00:00
개장가 저가 고가 종가 전일 종가
0.0891 0.0891
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
06/03/202422:31EDGAR2Form 8-K - Current report
07/02/202407:07EDGAR2Form 8-K - Current report
30/01/202421:00PRNUSInvitae Partners with BridgeBio Pharma to Harness Genetic..
30/01/202406:01EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
25/01/202406:34EDGAR2Form 8-K/A - Current report: [Amend]
22/01/202421:05EDGAR2Form 8-K - Current report
22/01/202421:00PRNUSInvitae Completes Sale of Reproductive Health Assets to..
19/01/202406:10EDGAR2Form 8-K - Current report
22/12/202311:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/12/202311:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/12/202306:29EDGAR2Form 8-K - Current report
14/12/202306:07PRNUSInvitae Divests Ciitizen Health Data Platform and Implements..
12/12/202306:41EDGAR2Form 8-K - Current report
18/11/202306:48EDGAR2Form 8-K - Current report
16/11/202306:22EDGAR2Form 8-K - Current report
15/11/202309:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/11/202309:55EDGAR2Form 3 - Initial statement of beneficial ownership of..
09/11/202306:36EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202306:05EDGAR2Form 8-K - Current report
09/11/202306:01PRNUSInvitae Reports Third Quarter 2023 Financial Results
07/11/202306:00PRNUSInvitae Launches Enhanced Chemistry of MRD Test to Better..
01/11/202319:59PRNUSInvitae to Announce Third Quarter 2023 Financial Results on..
26/10/202300:00PRNUSLandmark Study Reveals Magnitude of Uncertain Results in..
21/10/202307:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/10/202305:38EDGAR2Form 8-K - Current report
20/10/202305:30PRNUSInvitae Appoints Dr. David Sholehvar as Chief Operating..
13/10/202305:15PRNUSRural Hospital System Demonstrates the Clinical Benefits of..
11/10/202305:30PRNUSInvitae to Present Data at the National Society of Genetic..
04/10/202301:07PRNUSInvitae's Common Hereditary Cancers Panel Receives FDA..
03/10/202310:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/10/202309:47EDGAR2Form 3 - Initial statement of beneficial ownership of..
30/09/202309:00DJNFDA Gives Marketing Authorization to Invitae Test for Cancer..
28/09/202305:29EDGAR2Form 8-K - Current report
26/09/202307:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/09/202305:30PRNUSInvitae Announces Appointment of Finance Veteran Ana Schrank..
23/09/202306:02EDGAR2Form 8-K - Current report
23/09/202305:30PRNUSInvitae Receives Notice of Non-Compliance with NYSE Minimum..
15/09/202306:21EDGAR2Form 3 - Initial statement of beneficial ownership of..
29/08/202305:02PRNUSInvitae Hires Industry Veteran Robert Guigley as Chief..
23/08/202321:12EDGAR2Form 8-K - Current report
15/08/202320:30PRNUSClinical Trial Results Support Genetic Testing of All..
15/08/202305:02PRNUSInvitae Announces Selection of Finance Executive Robert..
11/08/202305:03EDGAR2Form 424B2 - Prospectus [Rule 424(b)(2)]
11/08/202305:01EDGAR2Form 424B2 - Prospectus [Rule 424(b)(2)]
10/08/202313:15EDGAR2Form EFFECT - Notice of Effectiveness
09/08/202322:22EDGAR2Form POS AM - Post-Effective amendments for registration..
09/08/202322:20EDGAR2Form POS AM - Post-Effective amendments for registration..
09/08/202305:40EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/08/202305:09EDGAR2Form 8-K - Current report
09/08/202305:01PRNUSInvitae Reports Second Quarter 2023 Financial Results

최근 히스토리

Delayed Upgrade Clock